OPTUS Pharmaceutical Co., Ltd. (KOSDAQ: 131030)

OPTUS Pharmaceutical Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	37,050	17,811	10,409	32,555	42,423	35,157
Short-Term Investments	22,000	40,000	40,000	42,000	39,973	34,000
Trading Asset Securities	503.77	10,711	11,146	-	-	-
Cash & Short-Term Investments	59,554	68,522	61,555	74,555	82,395	69,157
Cash Growth	-9.00%	11.32%	-17.44%	-9.52%	19.14%	16.88%
Accounts Receivable	9,510	9,321	7,472	6,313	3,875	7,308
Other Receivables	673.57	632.99	418.49	223.12	208.61	317.95
Receivables	10,223	9,995	7,908	6,564	4,108	13,656
Inventory	14,432	13,071	11,622	9,791	6,748	5,820
Prepaid Expenses	218.35	137.33	83.78	105.4	65.87	17.64
Other Current Assets	84.4	46.08	217.78	1	113.44	8.83
Total Current Assets	84,511	91,772	81,386	91,017	93,431	88,659
Property, Plant & Equipment	49,226	42,501	43,735	38,717	28,267	24,138
Long-Term Investments	12,469	13,497	10,121	9,636	8,127	5,709
Other Intangible Assets	7,228	-	-	-	-	-
Long-Term Accounts Receivable	-	-	-	-0	-0	-0
Long-Term Deferred Tax Assets	-	-	-	614.46	-	370.42
Other Long-Term Assets	618.09	1,647	963.78	53.31	71.77	91.77
Total Assets	154,069	149,460	136,240	140,038	129,897	118,969
Accounts Payable	2,064	1,889	1,536	1,519	1,213	1,118
Accrued Expenses	6,968	7,976	5,804	4,885	3,908	5,935
Current Portion of Leases	710.68	713.48	680.29	73.11	108.03	102.08
Current Income Taxes Payable	580.48	1,147	289.1	1,197	1,283	1,148
Other Current Liabilities	2,437	1,347	1,450	3,701	2,070	1,413
Total Current Liabilities	12,761	13,072	9,760	11,375	8,582	9,715
Long-Term Leases	935.83	1,359	1,918	167.1	352.32	72.91
Long-Term Deferred Tax Liabilities	345.53	494.15	14.92	-	828.05	-
Other Long-Term Liabilities	154.82	83.75	79.51	0	-	-
Total Liabilities	14,586	15,009	11,773	13,018	11,014	11,222
Common Stock	8,282	8,282	8,282	8,282	8,282	8,282
Additional Paid-In Capital	36,555	36,553	36,663	36,663	36,663	36,663
Retained Earnings	100,020	95,689	86,636	85,281	77,034	63,887
Treasury Stock	-5,655	-5,751	-6,352	-3,068	-3,068	-1,048
Comprehensive Income & Other	280.17	-322.28	-762.48	-137.35	-28.86	-37.65
Shareholders' Equity	139,483	134,451	124,467	127,021	118,883	107,747
Total Liabilities & Equity	154,069	149,460	136,240	140,038	129,897	118,969
Total Debt	1,647	2,073	2,598	240.2	460.35	175
Net Cash (Debt)	57,907	66,450	58,956	74,315	81,935	68,982
Net Cash Growth	-8.40%	12.71%	-20.67%	-9.30%	18.78%	16.59%
Net Cash Per Share	3792.60	4374.13	3717.13	4635.53	5079.34	4225.17
Filing Date Shares Outstanding	15.27	15.26	15.17	16.04	16.04	16.32
Total Common Shares Outstanding	15.27	15.26	15.17	16.04	16.04	16.32
Working Capital	71,750	78,700	71,626	79,642	84,849	78,945
Book Value Per Share	9131.90	8811.11	8207.04	7918.38	7411.07	6600.21
Tangible Book Value	132,255	134,451	124,467	127,021	118,883	107,747
Tangible Book Value Per Share	8658.66	8811.11	8207.04	7918.38	7411.07	6600.21
Land	5,271	5,271	5,478	5,584	5,584	1,994
Buildings	18,720	19,188	19,938	16,130	13,534	13,972
Machinery	11,984	13,387	14,420	4,577	5,406	6,017
Construction In Progress	11,227	1,999	506.56	12,183	3,291	1,981

Source: S&P Capital IQ. Standard template. Financial Sources.